You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
昭衍新藥(06127.HK):孫雲霞、顧曉磊分別減持21萬股、125萬股

格隆匯12月1日丨昭衍新藥(06127.HK)發佈公吿,孫雲霞、高大鵬、顧曉磊、顧美芳於2021年8月13日披露了減持計劃,自減持計劃公吿之日起15個交易日後的6個月內,通過上海證券交易所集中競價的交易方式分別減持不超過66.5萬股、5.8萬股、227萬股、152萬股,合計減持不超過451.3萬股A股,不超過公司當時總股本的1.19%。截止該公吿日,孫雲霞、顧曉磊分別減持了20.996萬股、125.294萬股,高大鵬、顧美芳未減持公司股份。減持計劃尚未實施完畢。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account